53
53802LAB8
Livanova Plc
Could not find a ticker for this position, may be a filing error
A medical technology company that makes devices for two very different jobs: VNS Therapy, an implanted device that sends gentle electrical pulses to the vagus nerve to reduce seizures in people with drug-resistant epilepsy, and heart-lung machines and oxygenators that keep blood flowing during open-heart surgery. It was born in 2015 from the merger of Italy's Sorin (a cardiovascular specialist founded in 1956) and Texas's Cyberonics (a neuromodulation pioneer). The name blends "life" and "nova" (Latin for "new") — a nod to the company's mission of giving patients a new life.
CONVERTIBLECUSIP: 53802LAB8HealthcareGB1 derivative reporter
2.5% convertible bond due March 15, 2029
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
